All terms in HP

Label Id Description
Decreased low-density lipoprotein particle size HP_0032193 [An abnormal decrease in the average size of low-density lipoprotein particle size in the blood circulation.]
Abnormal circulating cholesterol concentration HP_0003107 [Any deviation from the normal concentration of cholesterol in the blood circulation.]
Hydatidiform mole HP_0032192 [Hydatidiform mole (HM) is an aberrant human pregnancy with absence of, or abnormal embryonic development, hydropic degeneration of chorionic villi, and excessive proliferation of the trophoblast.]
Torn meniscus HP_0032191 [A tear in the cartilaginous pad (meniscus) of the knee.]
Abnormal meniscus morphology HP_0032190 [Abnormal structure of the meniscus of the knee, two crescent shape fibrocartilaginous pads that disperse the weight of the body and reduce friction of the knee joint during movement.]
left external ear UBERON_0006617 [An external ear that is in the left side of a multicellular organism.]
Abnormal prothrombin time HP_0032199 [Any deviation from the normal amount of time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.]
Decreased prothrombin time HP_0032198 [Abnormally short time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.]
Deep S wave in lead V5 HP_0032197 [Abnormal depth of the S wave in lead V5 of the electrocardiogram.]
Prominent S wave in lead I HP_0032196 [Increased amplitude (0.1 mV or more) and/or duration (40 ms or more) of the S wave as measured in lead I of the electrocardiogram.]
anterior abdominal wall UBERON_0006635 [The abdominal wall represents the boundaries of the abdominal cavity. The abdominal wall is split into the posterior (back), lateral (sides) and anterior (front) walls. There is a common set of layers covering and forming all the walls: the deepest being the extraperitoneal fat, the parietal peritoneum, and a layer of fascia which has different names over where it covers (eg transversalis, psoas fascia). Superficial to these, but not present in the posterior wall are the three layers of muscle, the transversus abdominis (transverse abdominal muscle), the internal (obliquus internus) and the external oblique (obliquus externus).]
coracoid process of scapula UBERON_0006633 [A process of the scapula in most mammals representing the remnant of the coracoid bone of lower vertebrates thas has become fused with the scapula.]
musculo-phrenic artery UBERON_0006632 [An artery with its origin in the lateral terminal branch of the internal thoracic artery, with distribution to the diaphragm and the intercostal muscles, and with anastomoses to the branches of the pericardiacophrenic and inferior phrenic.]
phrenic artery UBERON_0002057 [An artery that supplies the diaphragm.]
negative regulation of fibrinolysis GO_0051918 [Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.]
regulation of fibrinolysis GO_0051917 [Any process that modulates the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.]
positive regulation of fibrinolysis GO_0051919 [Any process that activates, maintains or increases the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.]
tooth of lower jaw UBERON_0003268 [A calcareous tooth that is part of the lower jaw region. In mammals, the lower jaw teeth are attached to the mandible (dentary).]
cuspid UBERON_0003674 [A tooth that is typically long and pointed and bearing a single cusp.]
tooth of upper jaw UBERON_0003267 [A calcareous tooth that is part of the upper jaw region. In mammals, the upper jaw teeth are attached to the maxilla.]